# Celldex Therapeutics, Inc.: Form 8-K, filed Jan 6, 2011

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2011-01-06
- Accepted by EDGAR: Jan 6, 2011, 08:06 ET
- Period: 2010-12-30
- Accession: 0001104659-11-000565
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465911000565/a11-1130_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465911000565/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465911000565/a11-1130_18k.htm

Filed Jan 6, 2011.
Source: SEC EDGAR, the filing index for accession 0001104659-11-000565. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
